Clinical Trial Detail

NCT ID NCT01476839
Title Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors City of Hope Medical Center
Indications

Hodgkin's lymphoma

Therapies

Basiliximab + 90Y basiliximab + Carmustine + Cytarbine + Etoposide + Melphalan

Age Groups: adult senior

No variant requirements are available.